Ayurnesh Pharmaceutical Private Limited
About Ayurnesh Pharmaceutical Private Limited
Data last updated:
Ayurnesh Pharmaceutical Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2018PTC046583. Its GSTIN is 23AARCA3151G1ZV (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashish Kumar Sthapak and Shanti Bai Sthapak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 77 Laxmi Nagar Vidhisa Road Bhanpur, Bhopal, Madhya Pradesh, India – 462037.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.68 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹1,810 (net margin 0.2%) and EBITDA of ₹2,446 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 140% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address77 Laxmi Nagar Vidhisa Road Bhanpur, Bhopal, Madhya Pradesh, India – 462037
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ayurnesh Pharmaceutical Private Limited
The main business activity of Ayurnesh Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ayurnesh Pharmaceutical Private Limited FY 2025 filings available
Ayurnesh Pharmaceutical Private Limited reported revenue of ₹11.68 Lakh (down 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ayurnesh Pharmaceutical Private Limited
Revenue fell 17% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 140%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ayurnesh Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2,446 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,810 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ayurnesh Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ayurnesh Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ayurnesh Pharmaceutical Private Limited
Ayurnesh Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Kumar Sthapak | Director | 19 Sep 2018 | 8 Years 1 Months | Current |
| Shanti Bai Sthapak | Director | 10 Feb 2021 | 5 Years 8 Months | Current |
Peer Comparison of Ayurnesh Pharmaceutical Private Limited
Ayurnesh Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other Hospital and Medical Care Activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anglo-Us Chemicals Private Limited | ₹11.73 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Agra, Uttar Pradesh, India |
| Biogenix Pharma Private Limited | ₹11.72 Lakh (FY 2024) | •••• | •••• | 113.0% | •••• | Chennai, Tamil Nadu, India |
| Just Health and Wellness Private Limited | ₹11.71 Lakh (FY 2024) | •••• | •••• | 18.0% | •••• | Jaipur, Rajasthan, India |
| Express Meditech Private Limited | ₹11.71 Lakh (FY 2021) | •••• | •••• | -71.0% | •••• | New Delhi, Delhi, India |
| Composite Healthcare Solutions Private Limited | ₹11.69 Lakh (FY 2024) | •••• | •••• | 98.0% | •••• | Khurja, Uttar Pradesh, India |
| Ayurnesh Pharmaceutical Private Limited this company | ₹11.68 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | Bhopal, Madhya Pradesh, India |
| Orcked Healthcare Private Limited | ₹11.66 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | Allahabad, Uttar Pradesh, India |
| Brine Life Sciences Private Limited | ₹11.65 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Burdwan, West Bengal, India |
| Tattva Healthcare Private Limited | ₹11.64 Lakh (FY 2017) | •••• | •••• | 133.0% | •••• | Mumbai, Maharashtra, India |
| Rasva Life Science Private Limited | ₹11.63 Lakh (FY 2025) | •••• | •••• | 22.0% | •••• | Thane, Maharashtra, India |
| Safe Drugs Health Solutions Private Limited | ₹11.63 Lakh (FY 2023) | •••• | •••• | 34126.0% | •••• | Miryalguda, Telangana, India |
Peers are the five companies nearest above and the five nearest below Ayurnesh Pharmaceutical by revenue in the same principal business activity (Other Hospital and Medical Care Activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Ayurnesh Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ayurnesh Pharmaceutical Private Limited
Ayurnesh Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ayurnesh Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Ayurnesh Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ayurnesh Pharmaceutical Private Limited
Ayurnesh Pharmaceutical Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Parvat Rao Adlak ceased to be Director on 12 Feb 2021.
Credit Ratings, Litigation & Regulatory Alerts for Ayurnesh Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ayurnesh Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ayurnesh Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ayurnesh Pharmaceutical Private Limited
Ayurnesh Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AARCA3151G1ZV | Madhya Pradesh | Active | 02 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ayurnesh Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ayurnesh Pharmaceutical Private Limited
Ayurnesh Pharmaceutical is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 September 2018 (8+ years old) and is registered under CIN U74999MP2018PTC046583.
Ayurnesh Pharmaceutical reported revenue of ₹11.68 Lakh for FY 2024 (down 17% YoY).
Ayurnesh Pharmaceutical has 2 current directors:
- Ashish Kumar Sthapak - Director
- Shanti Bai Sthapak - Director
Ayurnesh Pharmaceutical reported a net profit of ₹1,810 (net margin 0.2%) and EBITDA of ₹2,446 (EBITDA margin 0.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ayurnesh Pharmaceutical is 140% over three years. In the latest year (FY 2024) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ayurnesh Pharmaceutical is 23AARCA3151G1ZV, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Ayurnesh Pharmaceutical is U74999MP2018PTC046583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ayurnesh Pharmaceutical was incorporated on 19 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ayurnesh Pharmaceutical by revenue are Anglo-Us Chemicals Private Limited, Biogenix Pharma Private Limited, Just Health and Wellness Private Limited, Express Meditech Private Limited, Composite Healthcare Solutions Private Limited and 5 more, all in the same principal business activity (Other Hospital and Medical Care Activities).
Parvat Rao Adlak ceased to be Director on 12 Feb 2021. Satish Katare ceased to be Director on 12 Feb 2021. Shanti Bai Sthapak was appointed as Director on 10 Feb 2021. Ayurnesh Pharmaceutical has 4 board changes on record in total.
The registered office of Ayurnesh Pharmaceutical is at 77 Laxmi Nagar Vidhisa Road Bhanpur, Bhopal, Madhya Pradesh, India – 462037.